Abstract
1. The activities of adenine phosphoribosyltransferase and hypoxanthine phosphoribosyltransferase in extracts of rat and mouse liver, brain, spleen, heart and kidney, of rat bone marrow and of Ehrlich ascites-tumour cells have been measured. The specific activity of adenine phosphoribosyltransferase in tumour cells (3mμ-moles of nucleotide formed/min./mg. of protein) was between 15 and 60 times the activity of any mouse tissue examined. Hypoxanthine-phosphoribosyltransferase activity was greater in extracts of tumour cells than in mouse tissues, but the difference was not great. 2. The specific activities of both adenine phosphoribosyltransferase and hypoxanthine phosphoribosyltransferase in ascites-tumour cells decreased respectively by 57% and 36% 2 days after the cells had been inoculated into mice. After 4 days of tumour growth the specific activities of both enzymes increased, reaching a maximum at 10 days. 3. The activity of adenine phosphoribosyltransferase in rat-liver extracts increased steadily up to 4 days after partial hepatectomy, and was still above the control value after 14 days. Hypoxanthine-phosphoribosyltransferase activity in extracts of regenerating rat liver did not increase until the second day after operation and had begun to decrease by the fourth day. 4. From the results it was concluded that adenine phosphoribosyltransferase and hypoxanthine phosphoribosyltransferase may be physiologically important enzymes in rapidly growing tissues, and that inhibitors of the former enzyme have potential value in chemotherapy.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ATKINSON M. R., MURRAY A. W. INHIBITION BY 6-MERCAPTOPURINE OF PURINE PHOSPHORIBOSYLTRANSFERASES FROM EHRLICH ASCITES-TUMOUR CELLS THAT ARE RESISTANT TO THE DRUG. Biochem J. 1965 Jan;94:71–74. doi: 10.1042/bj0940071. [DOI] [PMC free article] [PubMed] [Google Scholar]
- ATKINSON M. R., MURRAY A. W. INHIBITION OF PRUINE PHOSPHORIBOSYLTRANSFERASES OF EHRLICH ASCITES-TUMOUR CELLS BY 6-MERCAPTOPURINE. Biochem J. 1965 Jan;94:64–70. doi: 10.1042/bj0940064. [DOI] [PMC free article] [PubMed] [Google Scholar]
- BRESNICK E. EARLY CHANGES IN PYRIMIDINE BIOSYNTHESIS AFTER PARTIAL HEPATECTOMY. J Biol Chem. 1965 Jun;240:2550–2556. [PubMed] [Google Scholar]
- DAVIDSON J. D., WINTER T. S. PURINE NUCLEOTIDE PYROPHOSPHORYLASES IN 6-MERCAPTOPURINE-SENSITIVE AND -RESISTANT HUMAN LEUKEMIAS. Cancer Res. 1964 Feb;24:261–267. [PubMed] [Google Scholar]
- DAVIDSON J. N., GOUTIER R., SMELLIE R. M., THOMSON R. Y. The incorporation of 14C-formate into nucleic acid bases in vitro and in vivo. Biochim Biophys Acta. 1956 Dec;22(3):585–587. doi: 10.1016/0006-3002(56)90078-6. [DOI] [PubMed] [Google Scholar]
- GERLACH E., DREISBACH R. H., DEUTICKE B. PAPER CHROMATOGRAPHIC SEPARATION OF NUCLEOTIDES, NUCLEOSIDES, PURINES, AND PYRAMIDINES. J Chromatogr. 1965 Apr;18:81–85. doi: 10.1016/s0021-9673(01)80323-x. [DOI] [PubMed] [Google Scholar]
- HENDERSON J. F., KHOO M. K. SYNTHESIS OF 5-PHOSPHORIBOSYL 1-PYROPHOSPHATE FROM GLUCOSE IN EHRLICH ASCITES TUMOR CELLS IN VITRO. J Biol Chem. 1965 Jun;240:2349–2357. [PubMed] [Google Scholar]
- KIMBALL A. P., LEPAGE G. A. METABOLIC EFFECTS OF 9-BUTYL-6-THIOGUANINE IN VIVO. Cancer Res. 1963 Dec;23:1792–1799. [PubMed] [Google Scholar]
- LAJTHA L. G., VANE J. R. Dependence of bone marrow cells on the liver for purine supply. Nature. 1958 Jul 19;182(4629):191–192. doi: 10.1038/182191a0. [DOI] [PubMed] [Google Scholar]
- LIEBERMAN I., OVE P. Enzyme studies with mutant mammalian cells. J Biol Chem. 1960 Jun;235:1765–1768. [PubMed] [Google Scholar]